Navigation Links
Omeros Corporation Reports First Quarter 2013 Financial Results
Date:5/10/2013

mary safety data expected to support the initiation of OMS721 clinical studies in mid-year 2013. The pharmacokinetic results in primates demonstrated that subcutaneous administration of OMS721 resulted in maximal inhibition of the lectin pathway within six hours of administration and maintained it for two or more weeks. In addition, the bioavailability and pharmacokinetics observed in both species are expected to support subcutaneous administration in patients at a frequency of once weekly, bi-monthly or possibly at even longer intervals.
  • Announced the successful completion of the 90-day safety database lock in the second of Omeros' two pivotal Phase 3 clinical trials evaluating OMS302 in patients undergoing intraocular lens replacement surgery. OMS302, added to standard irrigation solution used during ophthalmological procedures, is Omeros' proprietary PharmacoSurgery™ product designed to maintain intraoperative mydriasis and reduce postoperative pain and irritation resulting from cataract and other lens replacement surgery. Omeros intends to submit a New Drug Application for OMS302 to the U.S. Food and Drug Administration this quarter and a Marketing Authorization Application to the European Medicines Agency in mid-2013.
  • Reported that its proprietary Cellular Redistribution Assay technology, which to date has successfully "unlocked" 46 of the 80 total Class A orphan G protein-coupled receptors (GPCRs) for drug development, has identified small molecules that interact with a Class B GPCR. Like the Class A GPCRs, Class B receptors are important players in a broad range of disorders, having been linked to various types of cancer (e.g., breast, brain, prostate, kidney, liver, pancreatic and gastrointestinal); multiple sclerosis, attention deficit-hyperactivity, learning and memory impairments, depression and other neuropsychiatric disorders; multiple metabolic disorders including diabetes and obesity; immunologic disorders; osteoporosis and i
    '/>"/>

  • SOURCE Omeros Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
    2. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
    3. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
    4. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
    5. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
    6. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
    7. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
    8. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
    9. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
    10. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
    11. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... , July 30, 2015  Growth of the U.S. ... they bring former prescription users to the OTC market. ... forecasts robust Rx-to-OTC switch activity over the next ... along with many new brands entering the market into ... the next five years (even those with low to ...
    (Date:7/30/2015)...  Medimetriks Pharmaceuticals, Inc. announced today that its ... study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone ... U.S. rights to Ozenoxacin 1% cream.  ... with an emphasis on U.S. patients, involved 412 ... older with a clinical diagnosis of bullous or ...
    (Date:7/30/2015)... , July 30, 2015 Vermillion, ... on gynecologic disease, announced today it will ... after the market close on Thursday, August ... call and webcast at 4:30pm Eastern.Conference Call ... at 4:30pm Eastern/1:30pm Pacific  Domestic: ...
    Breaking Medicine Technology:Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
    (Date:7/31/2015)... , ... July 31, 2015 , ... ... of a wide variety of nutritional and wellness products, announced the addition of ... specializes in massage therapy, active isolated stretching and the prevention and rehabilitation of ...
    (Date:7/31/2015)... MN (PRWEB) , ... July 31, 2015 , ... ... deal. The same logic applies when purchasing disability insurance, where price is an ... Secura Consultants, along with a leading insurance carrier, offers the Preferred Producer Multi-Life ...
    (Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Dale Sky ... United States, will speak at the International Cannabis Professionals Expo held at the Caribe ... , The International Cannabis Professionals Expo is the largest medical cannabis expo ...
    (Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Committed to ... to action by asking community members to contribute to the College’s “My Brother’s Keeper ... of our young people stay on track. Providing the support they need to think ...
    (Date:7/30/2015)... , ... July 30, 2015 , ... OSF Healthcare ... results from the 2015 Most Wired Survey conducted by Hospitals & Health Networks. This ... system owned and operated by The Sisters of the Third Order of St. ...
    Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
    ... IRVINE, Calif., Dec. 5 ISTA Pharmaceuticals, Inc. (Nasdaq: ... President of Corporate Development, will participate in a panel discussion ... RBC Capital Markets Healthcare Conference. The panel will begin at ... New York. , , ...
    ... Closer look at tumors boosts chances for those denied under ... News) -- Many patients with liver cancer who don,t meet ... candidates for liver transplantation, according to an Italian study. , ... single tumor of 5 centimeters or less in diameter, or ...
    ... American adults do not engage in sufficient levels of daily exercise. Treadmill ... levels of inactivity. , ... Phoenix, AZ (Vocus) December 5, 2008 -- ... and Prevention (CDC) 2008 Physical Activity Guidelines for Americans released today showed ...
    ... LISLE, Ill., Dec. 5 Following a USGS study ... the publicly treated,water that was tested, the Water Quality ... , According to ... of about,130 man-made chemicals were not removed by public ...
    ... CompanyDissolvedRetiree Health Care Payments , , ... who are members of the Teamsters Union, held a rally yesterday ... 600 Teamster workers have been forced out on strike at Oak ... cut off health care benefits from retirees. , ...
    ... In recognition of the best,Florida nonprofits successfully addressing ... a Healthy Florida, the philanthropic affiliate,of Blue Cross and ... Award honorees at a ceremony in Orlando. , ... ) , ...
    Cached Medicine News:Health News:New Criteria Could Expand Number of Liver Transplant Candidates 2Health News:Exceeding the Government's Minimum Health Guidelines with a Treadmill Desk 2Health News:Exceeding the Government's Minimum Health Guidelines with a Treadmill Desk 3Health News:Chemicals Remain in Most Treated Water, Says Report 2Health News:Striking Oak Harbor Employees Honor Retirees 2Health News:Florida's Top Health Care Nonprofits Honored With 2008 Sapphire Awards 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: